000 | 01906ngm a2200481 a 4500 | ||
---|---|---|---|
001 | HST4903 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 191104s2019 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a4903 _bHenry Stewart Talks |
035 | _a(UkLoHST)4057 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aSilva, Ana Catarina, _u(University Fernando Pessoa, Portugal) _4spk |
|
245 | 1 | 0 |
_aNeed for drug delivery systems _h[electronic resource] : _bpart 1 / _cAna Catarina Silva. |
260 |
_aLondon : _bHenry Stewart Talks, _c2019. |
||
300 |
_a1 online resource (1 streaming video file (16 min.) : _bcolor, sound). |
||
490 | 1 |
_aDrug delivery, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Conventional pharmaceutical dosage forms -- Strategies to improve drug bioavailability -- Liposomes -- Micelles -- Nanoemulsions -- Microemulsions -- Nanoparticles -- Polymeric and lipidic nanoparticles -- Dendrimers -- Limitations of nanosystems. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 | _aDrug delivery systems. | |
650 | 0 |
_aDrugs _xDosage forms. |
|
650 | 0 | _aNanobiotechnology. | |
650 | 0 | _aNanomedicine. | |
650 | 2 | _aBiological Availability. | |
650 | 2 | _aDendrimers. | |
650 | 2 | _aDosage Forms. | |
650 | 2 | _aDrug Delivery Systems. | |
650 | 2 | _aLipids. | |
650 | 2 | _aLiposomes. | |
650 | 2 | _aMicelles. | |
650 | 2 | _aNanoparticles. | |
650 | 2 | _aNanotechnology. | |
650 | 2 |
_aPharmaceutical Preparations _xadministration & dosage. |
|
650 | 2 | _aPolymers. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pDrug delivery. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/4057/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/1038/ _3Series |
999 |
_c76146 _d76146 |